PARP Inhibitor Biomarkers Market Are Estimated To Witness High...

agregó una foto Health

2023-12-27 13:05:47 -

PARP Inhibitor Biomarkers Market Are Estimated To Witness High Growth Owing To Rising Demand As Companion Diagnostics

PARP (Poly ADP-Ribose Polymerase) inhibitor biomarkers are used for the stratification of patients with certain cancers like breast and ovarian cancer into those likely to respond to PARP inhibitor treatment and those unlikely to respond. They play an important role as companion diagnostics alongside PARP inhibitors drugs to identify patients with homologous recombination deficiency (HRD)...

0 Commentarios 0 Acciones 1K Views 0 Vista previa